Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS) [NA]

View source ↗

Summary

An upcoming clinical trial evaluating the efficacy and safety of Uracil 0.5% Plasters for treating hand-foot syndrome in cancer patients; enrollment is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Syndrome

Drugs mentioned

• Uracil 0.5% Plasters (uracil 0.5% plaster)

Snippet

Sponsor: Wooshin Labottach Co., Ltd. | Conditions: HFS | NA | Status: NOT_YET_RECRUITING